P

Vaxcyte
D

PCVX

33.140
USD
-0.51
(-1.52%)
مفتوح الان
حجم التداول
20,251
الربح لكل سهم
-4
العائد الربحي
-
P/E
-8
حجم السوق
4,270,036,968
الأخبار المقالات

العنوان: Vaxcyte

القطاع: Healthcare
الصناعة: Biotechnology
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to preventor treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.